Loading clinical trials...
Loading clinical trials...
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medtronic Cardiovascular
NCT06638268 · Aortic Stenosis, Cardiogenic Shock
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07469371 · Severe Aortic Stenosis
NCT07278310 · Symptomatic Severe Native Aortic Stenosis, Aortic Stenosis
NCT07035847 · Aortic Stenosis
University of Alabama at Birmingham
Birmingham, Alabama
Abrazo Arizona Heart Hospital
Phoenix, Arizona
Tucson Medical Center
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions